
Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV
Description
About Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV
The Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 Peptide (IEDB: 37851) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Matrix protein Peptide, H-LLTEVETYV-OH (Uniprot: P05775 aa: 3-11) from JPT is produced under strict quality control and quality management.
Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV - Specifications
- Peptide sequence: H-LLTEVETYV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Influenza
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV
References:
Read References with JPT’s Antigen Peptides
Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV has been described in:
Design and use of conditional MHC class I ligands., Nat Med, 2006 (PMID: 16462803)
Identification of novel avian influenza virus derived CD8+ T-cell epitopes., PLoS One, 2012 (PMID: 22384112)
MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape., Nat Struct Mol Biol, 2017 (PMID: 28218747)
Documentation
Documentation for Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV
Properties
Properties of Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Influenza |
Layout: | Freeze-dried in glass vial |
Organism: | Influenza A |
Protein Name: | Matrix protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV
Information | Values |
---|---|
Sequence: | H-LLTEVETYV-OH |
Specifications: | 9mer peptide as TFA salt |